Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

IMCD NV (IMCD.AS)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (€) Price Target (€) Rating
2022-02-28144.70-No Rating
2022-12-20136.65125.00Sell
2023-04-11142.10130.00Sell
2023-08-08130.35125.00Sell
2023-10-10118.30115.00Sell
2023-11-13130.00117.50Sell
2024-01-30140.40122.00Sell
2024-03-15160.25128.00Sell
2024-05-31139.40122.00Sell
2024-08-08140.00123.00Sell
2024-10-21153.45125.00Sell
2025-01-17145.00128.00Sell

Disclosures

  • UBS beneficially owned 1% or more of a class of this company`s common equity securities as of last month`s end (or the prior month`s end if this report is dated less than 10 days after the most recent month`s end).
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.